Monkeypox virus vaccine: Amid the worldwide outbreak of monkeypox, the World Health Organization (WHO) announced the approval of the first-ever Bavarian Nordic vaccine against monkeypox virus (MPXV). The modified Vaccinia Ankara-Bavarian Nordic or MVA-BN is indicated for vaccination against smallpox, monkeypox and related orthopoxvirus infection and disease in all adults 18 years of age and older. The vaccine is 76 percent effective This vaccine can be given as a 2-dose injection at an interval of 4 weeks. WHO said in a statement, “Available data suggest that a single dose MVA-BN…
Read Moreworld health organization approves first Bavarian Nordic Mpox vaccine to boost disease control in Africa
